Astrazeneca (AZN) Asset Writedowns and Impairment (2018)
Astrazeneca (AZN) posted Asset Writedowns and Impairment of $75.0 million for Q4 2018.
Powered by 
Analysis
Astrazeneca (AZN) Asset Writedowns and Impairment (2018) Analysis & Trends
Astrazeneca has reported Asset Writedowns and Impairment for 1 years, with the latest figure at $75.0 million in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Asml Holding | 611.99 Bn | 596.01 Bn | 5.90 Bn |
| 2 | Hsbc Holdings | 362.66 Bn | 362.66 Bn | - |
| 3 | General Electric | 329.78 Bn | 320.44 Bn | 6.95 Bn |
| 4 | Astrazeneca | 253.40 Bn | 248.11 Bn | 12.86 Bn |
| 5 | Citigroup | 232.11 Bn | -2,070.20 Bn | 24.75 Bn |
| 6 | Bhp | 215.33 Bn | 196.79 Bn | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - |
| 8 | Diageo | 196.58 Bn | 194.55 Bn | - |
| 9 | Unilever | 139.00 Bn | 131.97 Bn | - |
| 10 | Hdfc Bank | 117.46 Bn | 80.31 Bn | - |